20 The Pathology of Hodgkin’s Disease PATRICK A. TRESELER, MD, PHD HISTORY In 1832, Dr. Thomas Hodgkin, working at Guy’s Hospital in London, reported a series of seven…

1. IOSR Journal of PharmacyVol. 2, Issue 3, May-June, 2012, pp.345-363 Immunogenicity of BiopharmaceuticalsD.K.DasPost Graduate Department of Biotechnology, T.M.Bhagalpur…

1. How can a cluster investigation generate new knowledge ? The dioxin issue . Professor Jean-François Viel Faculty of Medicine Besançon, France 2. Introduction : environmental…

1. Minsk, Belarus 2009 State Establishment “N.N. Alexandrov National Cancer Centre of Belarus” 2. THE COUNCIL OF MINISTERS OF THE BYELORUSSIAN SSR Resolution On Intensifying…

Cancer Epidemiology in the Arab Region REVIEW Cancer Epidemiology and Control in the Arab World - Past, Present and Future Elsayed I Salim1, Malcolm A Moore*1,2, Jawad A…

Editors: Hillman, Robert S.; Ault, Kenneth A.; Rinder, Henry M. Title: Hematology in Clinical Practice, 4th Edition Copyright ©2005 McGraw-Hill > Table of Contents…

Hindawi Publishing Corporation Advances in Hematology Volume 2012, Article ID 507257, 8 pages doi:10.1155/2012/507257 Review Article HIV-Associated Hodgkin’s Lymphoma:…

Slide 1 Tumor Therapy with Monoclonal Antibodies Gerhard Moldenhauer Slide 2 Innate and Adaptive Immunity Slide 3 Lymphocyte Activation Slide 4 Effector Functions of Antibodies…

CANCER DRUG CLASSES The classes of drugs currently used in the cancer clinic are  1. DNA Binding Agents (intercalating and alkylating agents) Mitotic Spindle Inhibitors…

IOSR Journal of Pharmacy Vol. 2, Issue 3, May-June, 2012, pp.345-363 ISSN: 2250-3013 www.iosrphr.org 345 | P a g e Immunogenicity of Biopharmaceuticals D.K.Das Post Graduate…